Royal DSM and JLL Create Leading Pharma Services Company in USD 2.6 BN Transaction

November 19, 2013

JLL Partners (“JLL”), a leading middle-market private equity firm, and Royal DSM, the global Life Sciences and Materials Sciences company, today announced the creation of a new company, which will be a leading global contract development and manufacturing organization (CDMO) for the pharmaceutical industry with anticipated sales of around USD 2 billion. It will be 51% owned by JLL and 49% by DSM.  

 

Download full release here.  

Please reload

Archive
Please reload